[CAS NO. 9005-80-5] Inulin

Ships within

Stock

Price

Qty

Total

$0.00

Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis

request a quote

If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [9005-80-5]

Catalog

AS993248

Brand

Arctom Scientific

CAS

9005-80-5

DESCRIPTION [9005-80-5]

Overview

MDL	-
Molecular Weight	-
Molecular Formula	Unspecified
SMILES	[Inulin]

For research use only. We do not sell to patients.

1 Publications Citing Use of MCE

[1]FASEB J. 2021 Nov;35(11):e22003.

Summary

Inulin is a storage polysaccharide and belongs to a group of non-digestible carbohydrates, fructan. Inulin is from plants of the Compositae and Lilialiaceaes families, often used as a prebiotic, fat replacer, sugar replacer, texture modifier, plays beneficial role in gastric ^[1] .

IC50 & Target

Human Endogenous Metabolite

Clinical Trial

NCT Number	Sponsor	Condition	Start Date	Phase
NCT03914495	AdventHealth Translational Research Institute	NAFLD	May 21, 2019	Not Applicable
NCT03852069	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	Obesity	January 2016	Not Applicable
NCT01130792	Christian Medical College, Vellore, India\|Indian Council of Medical Research\|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\|Tufts Medical Center	Infectious Gastroenteritis	May 2010	Phase 1\|Phase 2
NCT02229500	Scottish Universities Environmental Research Centre\|Biotechnology and Biological Sciences Research Council\|University of Glasgow	Optimum Propionate Delivery to the Large Intestine	August 2014	Not Applicable
NCT01549782	Hospital General Universitario Gregorio Marañon	Prebiotics\|Microbiota\|Radiation Therapy Complication\|Endometrial Neoplasms	June 2005	Not Applicable
NCT01487759	KU Leuven	Crohn Disease	March 2008	Not Applicable
NCT03117322	Andrea Garcia Contreras\|Hospital Civil Juan I. Menchaca	Cerebral Palsy\|Chronic Constipation	June 5, 2017	Phase 4
NCT03348592	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\|George Washington University\|University of Pennsylvania	Chronic Kidney Diseases	October 2016	Not Applicable
NCT03829189	Max Planck Institute for Human Cognitive and Brain Sciences	Diet Modification\|Overweight	January 14, 2019	Not Applicable
NCT02773927	Centro Universitario de Ciencias de la Salud, Mexico	Metabolic Syndrome	January 2013	Phase 3
NCT03983434	Indiana University\|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	IBS - Irritable Bowel Syndrome	August 13, 2019	Early Phase 1
NCT01841073	Imperial College London	Prediabetes	March 2011	Not Applicable
NCT00826137	Soroka University Medical Center	Antibiotic-Associated Diarrhea	December 2008	Phase 3
NCT03711383	Maastricht University Medical Center	Obesity\|Pre Diabetes	February 20, 2018	Not Applicable
NCT01757379	KU Leuven	Short Chain Fatty Acids Bioavailability	April 2011	Not Applicable
NCT01810978	Dr. Sami Ulus Children´s Hospital	Congenital Heart Disease	October 2012	Not Applicable
NCT04172688	University of Calgary	Osteo Arthritis Knee\|Obesity	November 18, 2018	Not Applicable
NCT02846454	University of Reading	Overweight and Obesity	August 2016	Not Applicable
NCT04698330	Second Xiangya Hospital of Central South University	Type 1 Diabetes Mellitus\|Autoimmune Diabetes	May 2022	Phase 4
NCT00335504	National Cancer Institute (NCI)	Colon Cancer\|Precancerous Condition\|Rectal Cancer	March 2006	Phase 2
NCT01004484	University of North Carolina, Chapel Hill\|General Mills	Non-diarrhea Functional Bowel Symptoms	June 2009	Not Applicable
NCT03670875	Coordinación de Investigación en Salud, Mexico	Obesity in Childhood	January 8, 2018	Not Applicable
NCT03383809	University of Glasgow\|Scottish Universities Environmental Research Centre	Healthy	April 28, 2017	Not Applicable
NCT02467972	University of Sao Paulo\|Conselho Nacional de Desenvolvimento Científico e Tecnológico\|Fundação de Amparo à Pesquisa do Estado de São Paulo	Overweight\|Diabetes\|Constipation	April 2012	Not Applicable
NCT01807858	Dr. Sami Ulus Children´s Hospital	Necrotizing Enterocolitis\|Sepsis	October 2012	Not Applicable
NCT02548247	Beneo GmbH	Healthy\|Constipation	March 2011	Not Applicable
NCT02451189	Scottish Universities Environmental Research Centre\|NHS Greater Clyde and Glasgow\|University of Glasgow	Obesity\|Overweight	January 2015	Not Applicable
NCT03865706	Columbia University	Antibiotic Resistant Infection\|Nosocomial Infection\|Pathogen Transmission\|Nutrition Disorders\|Critical Illness\|Sepsis	October 14, 2019	Phase 2
NCT02727166	Hospital Universitari Vall d´Hebron Research Institute	Functional Gastrointestinal Disorders	November 2010	Not Applicable
NCT04124016	University of Parma\|Azienda Ospedaliero-Universitaria di Parma	Diet Modification	September 2, 2019	Not Applicable
NCT01963364	University of Nottingham	Evidence of Adaptation to Dietary Exposure to Fructans	October 2013	Not Applicable
NCT01913678	University of Copenhagen\|Arla Foods	Obesity	July 2013	Not Applicable
NCT00936416	University Health Network, Toronto	Glomerular Filtration Rate\|Renal Blood Flow	January 2010	Not Applicable
NCT02718885	University of Illinois at Urbana-Champaign\|Renal Research Institute	Bone Diseases, Endocrine\|Nutritional and Metabolic Diseases	May 2016	Early Phase 1
NCT01505023	Cindetec\|Nucitec SA de CV	Obesity	April 2006	Phase 2
NCT04670133	Brock University\|Dr. Peter C. Fritz, Periodontal Wellness & Implant Surgery	Periodontitis\|Periodontal Diseases\|Periodontal Pocket	June 1, 2022	Not Applicable
NCT01913665	Eskisehir Osmangazi University	Functional Constipation	September 2013	Not Applicable
NCT05213494	Tate & Lyle\|Biofortis Innovation Services	Gastrointestinal Tolerance	May 20, 2021	Not Applicable
NCT04949607	Centre for Neuro Skills\|University of Texas	Brain Injury, Chronic\|Brain Injuries, Traumatic	July 28, 2021	Not Applicable
NCT00431665	Medical University of Vienna	Renal Circulation\|Renal Plasma Flow\|Glomerular Filtration Rate\|Fatty Acids, Nonesterified	July 1999	Not Applicable
NCT05619341	University of Nottingham	Irritable Bowel	October 28, 2022	Not Applicable
NCT00319007	Radboud University Medical Center\|Dutch Cancer Society	Adenomatous Polyposis Coli	April 2006	Phase 2
NCT03840746	University of Glasgow\|Scottish Universities Environmental Research Centre	Healthy	July 11, 2018	Not Applicable
NCT03577145	University of Glasgow\|Scottish Universities Environmental Research Centre	Healthy Adults	July 27, 2017	Not Applicable
NCT05277090	Yanqing Li\|Shandong University	Healthy	March 15, 2022	Early Phase 1
NCT02778776	Centro Universitario de Ciencias de la Salud, Mexico	Metabolic Syndrome	January 2013	Phase 3
NCT03653481	Children´s Hospital of Philadelphia\|Beneo GmbH	Inflammatory Bowel Diseases	October 29, 2018	Not Applicable
NCT02518659	Radboud University Medical Center	Hypomagnesemia, Intestinal, With Secondary Hypocalcemia\|Drug Induced Hypomagnesemia	February 2014	Not Applicable
NCT03322514	Imperial College London\|University of Glasgow	Healthy Obesity, Metabolically\|Appetite Regulation	March 29, 2017	Not Applicable
NCT05254340	Indiana University	Healthy	August 1, 2021	Not Applicable
NCT04994353	Universitas Katolik Widya Mandala Surabaya	Diet, Healthy	December 14, 2020	Not Applicable
NCT01965210	Swedish University of Agricultural Sciences\|Uppsala University	Appetite Regulation	March 2013	Not Applicable
NCT05581615	Beneo-Institute\|University of Reading	Healthy	November 20, 2020	Not Applicable
NCT05353504	Max Planck Institute for Human Cognitive and Brain Sciences\|Universitätsklinikum Leipzig\|DFG - Deutsche Forschungs Gemeinschaft (German Research Foundation)\|Helmholtz-Zentrum für Umweltforschung - UFZ	Overweight and Obesity	March 8, 2022	Not Applicable
NCT00958529	University of Minnesota\|Cargill	Healthy	August 2008	Not Applicable
NCT04543877	USDA, Western Human Nutrition Research Center\|University of Minnesota	Inflammation\|Vaccine\|Intestinal Permeability\|Typhoid Fever	September 27, 2022	Early Phase 1
NCT02795559	University of Toronto\|Canadian Institutes of Health Research (CIHR)	Obesity\|Diabetes	March 2012	Not Applicable
NCT03995342	Xijing Hospital	Frailty Syndrome	August 1, 2019	Not Applicable
NCT05532488	University of Belgrade	Burn Injury\|Insulin Resistance\|Post Burn Insulin Resistance	August 1, 2023	Not Applicable
NCT03968003	Chulalongkorn University	Obesity	August 1, 2017	Not Applicable
NCT04263246	University of Novi Sad, Faculty of Sport and Physical Education	Exercise Performance	September 15, 2020	Not Applicable
NCT04114513	Atlas Biomed	Microbiome\|Metabolic Syndrome\|Cardiovascular Risk Factor\|Inflammation\|Dyslipidemias	November 25, 2019	Not Applicable
NCT04016350	University of Glasgow	Exercise\|Inulin Propionate Ester	February 5, 2015	Not Applicable
NCT00750438	Imperial College London	Obesity	September 2008	Not Applicable
NCT00938561	Tufts Medical Center\|Dialysis Clinic, Inc.	Chronic Kidney Disease	September 2009
NCT05399316	Experimental and Clinical Research Center	Gut Microbiota Dysbiosis and Nutrition	June 15, 2022	Not Applicable
NCT03803709	Université Catholique de Louvain	Alcoholism	July 4, 2017	Not Applicable
NCT05071131	Charite University, Berlin, Germany	Chronic Kidney Disease 5D	February 1, 2022	Not Applicable
NCT04459156	Texas A&M University	Chronic Obstructive Pulmonary Disease\|Aging	June 23, 2020	Not Applicable
NCT03265002	University of Nottingham	Irritable Bowel Syndrome	March 8, 2018	Not Applicable
NCT02346838	Virginia Polytechnic Institute and State University	Prediabetes	January 2014	Not Applicable
NCT03442348	Guy´s and St Thomas´ NHS Foundation Trust	Metabolic Disease\|Immune Function\|Cardiovascular Diseases\|Systemic Inflammation	May 31, 2018	Not Applicable
NCT01233024	University of Minnesota	Healthy	November 2010	Early Phase 1
NCT03710850	Charles University, Czech Republic\|Institute for Clinical and Experimental Medicine	Insulin Resistance\|Microbiome	May 1, 2018	Not Applicable
NCT01025375	Maastricht University Medical Center	Obesity	January 2009	Not Applicable
NCT04118010	Emory University	Cystic Fibrosis\|Dysbiosis	March 13, 2020	Phase 4
NCT04836637	University of Copenhagen\|Zealand University Hospital	Osteoporosis, Postmenopausal	May 17, 2021	Not Applicable
NCT03595306	Duke University	Healthy Gut Microbiota	May 1, 2018	Not Applicable
NCT05349903	Purdue University\|Nestlé	Appetitive Behavior\|Obesity\|Diabetes Mellitus, Type 2	November 10, 2021	Not Applicable
NCT04055246	Duke University\|Office of Naval Research (ONR)	Prebiotics and Human Behavior and Cognition	June 4, 2019	Not Applicable
NCT02009670	Maastricht University Medical Center\|Top Institute Food and Nutrition	Type 2 Diabetes Mellitus\|Obesity	February 2014	Not Applicable
NCT00117390	University Hospital, Ghent	Renal Function\|Critical Illness	June 2004	Not Applicable
NCT02569684	Oslo University Hospital\|Norwegian Diabetes Association\|Norwegian Extra Foundation for Health and Rehabilitation	Diabetes Type 2	October 2015	Not Applicable
NCT05504044	Clinical Nutrition Research Centre, Singapore\|Glico Asia Pacific Pte Ltd	Cardiovascular Diseases\|Metabolic Disease	October 25, 2019	Not Applicable
NCT04652921	University of Novi Sad, Faculty of Sport and Physical Education	Sarcopenia	September 15, 2020	Not Applicable
NCT02562014	University of Toronto	Obesity	February 2012	Not Applicable
NCT01483092	Swiss Federal Institute of Technology	Iron Absorption\|Gut Bacteria	August 2011	Not Applicable
NCT05423015	Universidad Autonoma de San Luis Potosí	Childhood Obesity\|Childhood Overweight	July 21, 2017	Not Applicable
NCT01925560	University of Illinois at Urbana-Champaign	Tolerance	January 2013	Not Applicable

Appearance

Solid

Source

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (Need ultrasonic)

H ₂ O : ≥ 50 mg/mL

* "≥" means soluble, but saturation unknown.

In Vivo:

1.

Add each solvent one by one: PBS

Solubility: 27.5 mg/mL (Infinity mM); Clear solution; Need ultrasonic
2.

Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

Solubility: ≥ 2.5 mg/mL (Infinity mM); Clear solution
3.

Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

Solubility: ≥ 2.5 mg/mL (Infinity mM); Clear solution

* All of the co-solvents are available by MCE.

References

[1] Shoaib M, et al. Inulin: Properties, health benefits and food applications. Carbohydr Polym. 2016 Aug 20;147:444-454.

Synonyms

Inulin

Alantin

Alant starch

Dahlin

Synantherin

Synantrin

Sinantrin

Synanthrin

Raftiline LS

Frutafit

Frutafit IQ

Raftiline HP

Raftiline ST

Fibruline

Frutafit HD

Inutec N 10GR

Inulin IQ

Raftiline

Raftiline GR

Fibruline Instant

Fibruline Long Chain

Fibruline LC

Inulin HD

Inutec N 25

Frutafit EXL

Frutafit TEX

Fibrulose

Fuji FF

Raftifeed IPS

Beneo HP

Frutagave PR 95

Frutagave SP 70

Ticaloid LC-CSR 2

LV 110

Beneo ST

Oliggo-Fiber F 97

Beneo GR

Oliggo-Fiber XL

Beneo

Inutec N 10

Fuji SS

Orafti Synergy

Fibrulose F 97

Orafti HPX

Frutafit CLR

Advax

Advax D

Beneo IPS

FruTEX

Fibruline XL

ORAFTI Synergy 1

Orafti HP

Prebiofeed

Orafti GR

Raftiline HPX

Raftifeed IPE

Fructo-fiber

Fuji FFSC

P95 FOS

Orafti L 95

Agave Inulin